cbdMD (YCBD) Cash from Discontinued Operations (2019 - 2021)
cbdMD (YCBD) posted Cash from Discontinued Operations of 7500.0 for Q3 2021, up 100.0% sequentially from 3750.0 in Q2 2021, and down 97.04% YoY from 253750.0 in Q3 2020.
cbdMD (YCBD) Cash from Discontinued Operations (2019 - 2021) Analysis & Trends
cbdMD has reported Cash from Discontinued Operations for 3 years, with the latest figure at 7500.0 in Q3 2021.
- Quarterly Cash from Discontinued Operations fell 97.04% year-over-year to 7500.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was 436167.0 (down 25.71% YoY) and the FY2021 annual result came in at 436167.0, down 25.71% from the prior year.
- Cash from Discontinued Operations grew to 7500.0 in Q3 2021 per YCBD's latest filing, from 3750.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 422417.0 in Q4 2020 and troughed at 2500.0 in Q1 2021.
- A 3-year average of 127906.25 and a median of 83333.0 in 2020 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2020 and 2021: Cash from Discontinued Operations jumped 153.45% in 2020, then sank 97.04% in 2021.
- Over 3 years, Cash from Discontinued Operations stood at 166667.0 in 2019, then soared by 153.45% to 422417.0 in 2020, then tumbled by 98.22% to 7500.0 in 2021.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 7500.0, 3750.0, and 2500.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 7,500.00 |
| Sep 30, 2021 | 7,500.00 |
| Jun 30, 2021 | 3,750.00 |
| Jun 30, 2021 | 3,750.00 |
| Mar 31, 2021 | 2,500.00 |
| Mar 31, 2021 | 2,500.00 |
| Dec 31, 2020 | 422,417.00 |
| Dec 31, 2020 | 422,417.00 |
| Sep 30, 2020 | 253,750.00 |
| Sep 30, 2020 | 253,750.00 |
| Jun 30, 2020 | 83,333.00 |
| Jun 30, 2020 | 83,333.00 |
| Mar 31, 2020 | 83,333.00 |
| Mar 31, 2020 | 83,333.00 |
| Dec 31, 2019 | 166,667.00 |
| Dec 31, 2019 | 166,667.00 |